---
title: "Zhengye Biotechnology files late-filing notice"
url: "https://aibio.space/news/zhengye-biotechnology-files-late-filing-notice-auditor-needs-more-time/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-04-29"
section: "Distress"
tickers: "NASDAQ:ZYBT"
source: "https://www.sec.gov/Archives/edgar/data/1975641/000121390025036786/ea0239767-nt20f_zhengye.htm"
summary: "The company says it is still compiling information for its annual report for the year ended December 31, 2024."
---

By the aibio.space news desk.

Sources

- [Zhengye Biotechnology Holding Limited NT 20-F (2025-04-29)](https://www.sec.gov/Archives/edgar/data/1975641/000121390025036786/ea0239767-nt20f_zhengye.htm)

[ZYBT](https://aibio.space/companies/zhengye-biotechnology/)

2025-04-29

# Zhengye Biotechnology files late-filing notice, auditor needs more time on 20-F

Tickers [ZYBT](https://aibio.space/companies/zhengye-biotechnology/)

The company says it is still compiling information for its annual report for the year ended December 31, 2024.

## Key facts

- **Company**: Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT)

- **News type**: Distress

- **Primary source**: [Zhengye Biotechnology Holding Limited NT 20-F (2025-04-29)](https://www.sec.gov/Archives/edgar/data/1975641/000121390025036786/ea0239767-nt20f_zhengye.htm)

*The facade of a neoclassical court building at dusk. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

Zhengye Biotechnology Holding Limited (Nasdaq: [ZYBT](https://aibio.space/companies/zhengye-biotechnology/)) filed a notice of late filing on April 29, 2025 for its annual report on Form 20-F for the fiscal year ended December 31, 2024.

The notice is a Form 12b-25. A company files it when it cannot make a periodic filing on time without unreasonable effort or expense, and it brings a short grace period of up to the fifteenth calendar day after the due date for an annual report.

Zhengye says the compilation and review of the information required in the Form 20-F "have imposed time constraints" that made timely filing impracticable without undue hardship and expense to the company. It says it is still compiling the required information. It also says its independent registered public accounting firm needs additional time to finish its review of the financial statements for the year.

Zhengye answered no when asked whether it expects a significant change in results of operations from the corresponding period for the last fiscal year.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

ZYBT

Zhengye Biotechnology Holding Limited

NASDAQ · China

Open the starter desk

## More in Distress

Distress

### [Mineralys takes ownership of lorundrostat patents but keeps Tanabe milestone debts](https://aibio.space/news/mineralys-takes-ownership-lorundrostat-patents-but-keeps-tanabe/)

Oct 29, 2026

Distress

### [Bristol Myers Squibb drops Prothena's PRX019, ending up to $617.5 million in milestones](https://aibio.space/news/bristol-myers-squibb-drops-prothenas-prx019-ending-up-617-5-million/)

Oct 29, 2026

Distress

### [LENZ Therapeutics reorganizes to cut 2027 operating expenses by more than 50%](https://aibio.space/news/lenz-therapeutics-reorganizes-cut-2027-operating-expenses-more-50/)

Oct 28, 2026

---
Source page: https://aibio.space/news/zhengye-biotechnology-files-late-filing-notice-auditor-needs-more-time/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Zhengye Biotechnology files late-filing notice", 2025-04-29, https://aibio.space/news/zhengye-biotechnology-files-late-filing-notice-auditor-needs-more-time/